Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
896 results
896
Total Filings
$6934.4B
Total Raised
69
424B4 Offerings
255
ATM Programs
127
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6 | BZAIW | — | — | — | Public Offering | — | — | — | 18.9M | — | — | Blaize Holdings, Inc. is selling 18,918,918 shares of common stock at $1.85 per share, raising approximately $35 million gross proceeds for general corporate purposes. |
| May 6 | TPET | Energy | Oil & Gas Exploration & Production | $3M | ATM | — | $0.31 | — | — | — | — | Trio Petroleum Corp is selling up to $65 million of common stock through an ATM agreement with Ladenburg Thalmann to raise capital for general corporate purposes. |
| May 6 | PMI | Healthcare | Surgical & Medical Instruments & Apparatus | $218M | Public Offering |
$0.35
floor
|
$0.14 | -60.0% | 16.7M | $6M | — | Picard Medical is raising approximately $5 million by selling 16.7 million common shares and warrant packages at $0.30 per unit, with proceeds for general corporate purposes and working capital. |
| May 6 | RSI | Consumer Cyclical | Gambling, Resorts & Casinos | $8.0B | Public Offering | — | $33.51 | — | — | — | Wells Fargo, Morgan Stanley, Jefferies, Needham, Oppenheimer | Selling holders are offering 10 million Rush Street Interactive Class A shares at $26 per share for $260 million in gross proceeds; RSI will not receive proceeds but will repurchase 1.15 million shares. |
| May 5 | CYTK | Healthcare | Biotechnology | $10.2B | Public Offering |
$66.05
floor
|
$81.93 | +24.0% | — | — | Jefferies | Cytokinetics is selling $650 million in common stock at an undisclosed price per share; underwriters have a 30-day option to purchase an additional $97.5 million; proceeds and use not specified. |
| May 5 | CLNN | Healthcare | Biotechnology | $64M | Public Offering |
$7.00
floor
|
$6.19 | -11.6% | — | — | — | Clene Inc. is selling 1,000,000 shares of common stock at $7.00 per share, raising $7,000,000 gross proceeds ($6,545,000 net after underwriting fees). |
| May 5 | CLNN | Healthcare | Biotechnology | $64M | Public Offering | — | $6.19 | — | — | — | — | Clene Inc. is offering shares of common stock at an undisclosed price per share to raise an unspecified amount; specific pricing and use of proceeds details are incomplete in this preliminary prospectus supplement. |
| May 5 | AVTX | Healthcare | Biotechnology | $208M | Public Offering |
$13.78
floor
|
$18.42 | +33.7% | — | — | Cowen, BofA | Aveo Pharmaceuticals is offering common stock and pre-funded warrants at $13.78 per share (May 4, 2026 price) to raise capital, with proceeds for general corporate purposes. |
| May 5 | RDZNW | — | — | — | Public Offering | — | — | — | — | — | — | Roadzen Inc. is offering 4,705,870 ordinary shares at $1.70 per share on a best efforts basis, raising up to $8.0 million for general corporate purposes. |
| May 5 | AURA | Healthcare | Biological Products, (No Diagnostic Substances) | $449M | Public Offering | — | $7.00 | — | 39.6M | — | Cowen, Evercore | Aura Biosciences offers 39.6M common shares at $6.00 and 3.8M pre-funded warrants at $5.99999, raising ~$260.3M gross proceeds; $39M to repurchase Matrix Capital's shares. |
| May 5 | DVLT | Technology | Information Technology Services | $109M | Public Offering | — | $0.39 | — | 109.1M | — | — | Datavault AI Inc. is offering 109,090,910 shares of common stock at $0.55 per share to raise approximately $60 million in a registered direct offering, with proceeds for general corporate purposes. |
| May 5 | BZAIW | — | — | — | Public Offering | — | — | — | — | — | — | Blaize Holdings, Inc. is conducting a preliminary public offering of common stock on Nasdaq (BZAI); specific share count, price, and proceeds amounts are not yet completed in this preliminary 424B5 filing. |
| May 5 | IDYA | Healthcare | Biotechnology | $3.5B | ATM | — | $36.65 | — | — | — | Jefferies | IDYA is offering up to $156.6 million in remaining common stock at-the-market through Jefferies, with $193.4 million already sold; proceeds fund general corporate purposes. |
| May 5 | OBAI | — | — | $9M | Public Offering | — | $0.65 | — | 34.1M | — | — | Our Bond, Inc. registered stockholders are selling up to 34,073,681 common shares via direct listing on Nasdaq Global Market under ticker OBAI; no pricing or proceeds use disclosed in supplement. |
| May 5 | BATL | Energy | Oil & Gas Exploration & Production | $28M | ATM | — | $1.68 | — | — | — | — | BATL may sell up to $150 million in common stock at-the-market through Roth Capital Partners; proceeds for general corporate purposes, with 3% agent commission. |
| May 5 | HYPD | Healthcare | Medical - Devices | $15M | Public Offering |
$4.50
floor
|
$2.96 | -34.2% | — | — | — | # Unable to Extract Complete Offering Details This preliminary prospectus supplement (424B5) cannot be fully analyzed as filed because **critical pricing and share quantity information is redacted** (shown as blank spaces). The document shows placeholders for: - Number of common shares offered - Number of pre-funded warrants offered - Per-share offering price - Total offering proceeds |
| May 4 | VXRT | Healthcare | Biotechnology | $133M | ATM | — | $0.55 | — | — | — | B. Riley | Vexrt is selling up to $49.8 million of common stock through an at-the-market offering via Citizens JMP Securities and B. Riley Securities, with proceeds for general corporate purposes. |
| May 4 | RNTX | Healthcare | Medical - Pharmaceuticals | $26M | Secondary |
$1.00
floor
|
$0.92 | -8.4% | 50.0M | $50M | — | Rein Therapeutics is offering 50 million shares at $1.00 per share, raising $50 million gross proceeds for general corporate purposes and working capital. |
| May 4 | BHVN | Healthcare | Biotechnology | $1.6B | Public Offering | — | $14.94 | — | — | — | J.P. Morgan | Biohaven Ltd. is raising up to $350 million through an at-the-market equity distribution agreement with J.P. Morgan Securities LLC to sell common shares at prevailing market prices, with no specified use of proceeds disclosed. |
| May 4 | WTO | Technology | Consumer Electronics | $1M | Public Offering |
$0.50
floor
|
$7.20 | +1340.0% | — | — | — | UTIME Limited (WTO) is raising $880,000 through a registered direct offering of 200,000 Class A shares at $1.20 and 800,000 pre-funded warrants at $0.70 per warrant; proceeds will be used for general corporate purposes. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →